CIK 0001377121 · Large accelerated filer
Protagonist Therapeutics, Inc
Sign in to watch- Ticker
- PTGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980505495
- Phone
- (510) 474-0170
- Business address
- 7707 GATEWAY BLVD., SUITE 140, NEWARK, CA, 94560-1160
- Former names
- Protagonist Therapeutics Inc, Protagonist Inc
- PRE 14A Proxy Proxy Statement (Preliminary)
- 4 Planned sale President and CEO sold 25,000 shares at $28.31 ($707,750)
- 144 Insider Sale of Securities
- 4 Option exercise Director acquired 6,490 shares (option exercise)
- 4 Planned sale President and CEO sold 30,000 shares at $31.62 ($948,600)
- 4 Planned sale Director sold 12,975 shares at $31.34 ($406,637)
- 4 Open-market sale Chief Financial Officer sold 24,187 shares at an average $31.60 ($764,365)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Shares withheld for taxes President and CEO gave up 10,915 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Development Officer gave up 4,282 shares (to pay taxes)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Shares withheld for taxes President and CEO gave up 3,717 shares (to pay taxes)
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
Page 11 of 36 · 707 filings